메뉴 건너뛰기




Volumn 22, Issue 8, 2006, Pages 677-680

Sumatriptan alleviates pain in patients with trigeminal neuralgia

Author keywords

Sumatriptan; Trigeminal neuralgia; Visual analog scale

Indexed keywords

CARBAMAZEPINE; SUMATRIPTAN; TRIPTAN DERIVATIVE;

EID: 33748937219     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ajp.0000210917.18536.0d     Document Type: Article
Times cited : (37)

References (18)
  • 1
    • 0035654409 scopus 로고    scopus 로고
    • Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia
    • Rozen TD. Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia. Headache. 2000;41:S25-S32.
    • (2000) Headache , vol.41
    • Rozen, T.D.1
  • 2
    • 0029922472 scopus 로고    scopus 로고
    • The long-term outcome of microvascular decompression for trigeminal neuralgia
    • Barker FG II, Jannetta PJ, Bissonette DJ, et al. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med. 1996;334:1077-1083.
    • (1996) N Engl J Med , vol.334 , pp. 1077-1083
    • Barker II, F.G.1    Jannetta, P.J.2    Bissonette, D.J.3
  • 3
    • 50549189257 scopus 로고
    • Trigeminal neuralgia: Its treatment with a new anti-convulsant drug (G-32883)
    • Blom S. Trigeminal neuralgia: its treatment with a new anti-convulsant drug (G-32883). Lancet. 1962;i:839-840.
    • (1962) Lancet , vol.1 , pp. 839-840
    • Blom, S.1
  • 4
    • 0035904760 scopus 로고    scopus 로고
    • 1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials
    • 1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358:1668-1675.
    • (2001) Lancet , vol.358 , pp. 1668-1675
    • Ferrari, M.D.1    Roon, K.I.2    Lipton, R.B.3
  • 5
    • 0025816337 scopus 로고
    • The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan
    • Fowler PA, Lacey LF, Thomas M, et al. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol. 1991;31:291-294.
    • (1991) Eur Neurol , vol.31 , pp. 291-294
    • Fowler, P.A.1    Lacey, L.F.2    Thomas, M.3
  • 6
    • 0031898120 scopus 로고    scopus 로고
    • Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, 100 mg) in the acute treatment of migraine: Defining the optimum doses of oral supatriptan
    • Pfaffenrath V, Cunin G, Sjonell G, et al. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, 100 mg) in the acute treatment of migraine: defining the optimum doses of oral supatriptan. Headache. 1998;38:184-190.
    • (1998) Headache , vol.38 , pp. 184-190
    • Pfaffenrath, V.1    Cunin, G.2    Sjonell, G.3
  • 7
    • 33749205615 scopus 로고    scopus 로고
    • A double-blind placebo-controlled study assessing the efficacy and tolerability of 50mg sumatriptan tablets in the acute treatment of migraine
    • Sumatriptan Tablets S2CM07 Study Group
    • Savani N, Brautaset NJ, Reunanen M, et al. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group. Int J Clin Pract. 1999;105(Suppl):7-15.
    • (1999) Int J Clin Pract , vol.105 , Issue.SUPPL. , pp. 7-15
    • Savani, N.1    Brautaset, N.J.2    Reunanen, M.3
  • 8
    • 0036850382 scopus 로고    scopus 로고
    • 1A receptor activation: A new mechanism of profound central analgesia
    • 1A receptor activation: a new mechanism of profound central analgesia. Neuropharmacology. 2002;43:945-958.
    • (2002) Neuropharmacology , vol.43 , pp. 945-958
    • Colpaert, F.C.1    Tarayre, J.P.2    Koek, W.3
  • 9
    • 0029813854 scopus 로고    scopus 로고
    • Differential expression of sumatriptan-sensitive 5-hydroxy-tryptamine receptors in human trigeminal ganglia and cerebral blood vessels
    • Bouchelet I, Cohen Z, Case B, et al. Differential expression of sumatriptan-sensitive 5-hydroxy-tryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol. 1996;50:219-223.
    • (1996) Mol Pharmacol , vol.50 , pp. 219-223
    • Bouchelet, I.1    Cohen, Z.2    Case, B.3
  • 10
    • 0035063723 scopus 로고    scopus 로고
    • An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system
    • Limmroth V, Katsarava Z, Liedert B, et al. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain. 2001;92:101-106.
    • (2001) Pain , vol.92 , pp. 101-106
    • Limmroth, V.1    Katsarava, Z.2    Liedert, B.3
  • 11
    • 0024379698 scopus 로고
    • Percutaneous injection of glycerol for the treatment of trigeminal neuralgia
    • Waltz TA, Dalessio DJ, Copeland B, et al. Percutaneous injection of glycerol for the treatment of trigeminal neuralgia. Clin J Pain. 1989;5:195-198.
    • (1989) Clin J Pain , vol.5 , pp. 195-198
    • Waltz, T.A.1    Dalessio, D.J.2    Copeland, B.3
  • 12
    • 0027054718 scopus 로고
    • Glycerol injection to the rat trigeminal nerve: Histological and immunohistochemical studies
    • Hara H, Kobayashi S. Glycerol injection to the rat trigeminal nerve: histological and immunohistochemical studies. Acta Neurochir (Wien). 1992;119:111-114.
    • (1992) Acta Neurochir (Wien) , vol.119 , pp. 111-114
    • Hara, H.1    Kobayashi, S.2
  • 13
    • 0023684179 scopus 로고
    • Enrichment of a vasoactive neuropeptide (calcitonin gene-related peptide) in the trigeminal sensory projection to the intracranial arteries
    • O'Connor TP, van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene-related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci. 1988;8:2468-2476.
    • (1988) J Neurosci , vol.8 , pp. 2468-2476
    • O'Connor, T.P.1    Van Der Kooy, D.2
  • 14
    • 0022347682 scopus 로고
    • Calcitonin gene-related peptide is a potent inhibitor of substance P degradation
    • Le Greves P, Nyberg F, Terenius L, et al. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharmacol. 1985;115:309-311.
    • (1985) Eur J Pharmacol , vol.115 , pp. 309-311
    • Le Greves, P.1    Nyberg, F.2    Terenius, L.3
  • 15
    • 0023143665 scopus 로고
    • Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats
    • Oku R, Satoh M, Fujii N, et al. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res. 1987;403:350-354.
    • (1987) Brain Res , vol.403 , pp. 350-354
    • Oku, R.1    Satoh, M.2    Fujii, N.3
  • 16
    • 0023874663 scopus 로고
    • Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
    • Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23:193-196.
    • (1988) Ann Neurol , vol.23 , pp. 193-196
    • Goadsby, P.J.1    Edvinsson, L.2    Ekman, R.3
  • 17
    • 0030987440 scopus 로고    scopus 로고
    • Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia
    • Strittmatter M, Grauer M, Isenberg E, et al. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache. 1997;37:211-216.
    • (1997) Headache , vol.37 , pp. 211-216
    • Strittmatter, M.1    Grauer, M.2    Isenberg, E.3
  • 18
    • 0035207990 scopus 로고    scopus 로고
    • Trigeminal neuralgia: Pathology and pathogenesis
    • Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain. 2001;124:2347-2360.
    • (2001) Brain , vol.124 , pp. 2347-2360
    • Love, S.1    Coakham, H.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.